Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter of 2023.
- Avenue Therapeutics reported earnings per share of 56 cents. This was above the analyst estimate for EPS of -10 cents.
- The company did not report any revenue for the quarter.